Announcements Trials
Browse Landscape

Phase

Phase 2 99Phase 1 49Phase 1/2 40Phase NA 34Phase 3 20Phase 4 6Phase 2/3 6Phase EARLY_PHASE1 5

Status

Completed 3Unknown 2Recruiting 1

Sponsor Class

INDUSTRY 7OTHER 6NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Myeloid 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Thoracic Neoplasms 1Prostatic Neoplasms 1Mastocytosis 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Advanced Solid Tumor 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Injections × Clear all
NCT06282588 2026-03-19

THUNDER

Cancer Research Antwerp

Phase 2/3 Recruiting
493 enrolled
Genitourinary

Prostatic Neoplasms

NCT06009627 2026-02-10

Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients

Tianjin Medical University Cancer Institute and Hospital

Phase 2/3 Completed
119 enrolled
Breast

Breast Neoplasms

NCT04209868 2024-03-29

ParaSOL

Guy's and St Thomas' NHS Foundation Trust

Phase 2/3 Unknown
100 enrolled
Thoracic

Thoracic Neoplasms

NCT05809336 2023-04-12

Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors

Beijing Friendship Hospital

Phase 2/3 Completed
172 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT05280444 2022-12-29

Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma

Zhongda Hospital

Phase 2/3 Unknown
216 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01333293 2016-01-18

XOLMA

University of Zurich

Phase 2/3 Completed
17 enrolled
Myeloid

Mastocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡